References

References for article

SUBHASH C. BHATIA, M.D.,
is chief of the Mental Health and Behavioral Science Department at the Department of Veterans Affairs Medical Center, Omaha, Neb. He is also associate professor of psychiatry and family practice at Creighton University School of Medicine and clinical associate professor at the University of Nebraska College of Medicine, both in Omaha. A medical graduate of Panjab University, Chandigarh, India, Dr. Bhatia received a graduate degree from the Postgraduate Institute of Medical Education and Research, also in Chandigarh, and completed a residency in psychiatry at Creighton University. Dr. Bhatia is board-certified in psychiatry, geriatric psychiatry and addiction psychiatry.

SHASHI K. BHATIA, M.D.,

advertisement

is director of child and adolescent residency education and training at Creighton University School of Medicine, where she is also associate professor of psychiatry, child and adolescent psychiatry, and pediatrics. In addition, she serves as clinical associate professor at the University of Nebraska College of Medicine. A medical graduate of Panjab University, Dr. Bhatia completed a residency in obstetrics and gynecology at the Postgraduate Institute of Medical Education and Research and a residency in psychiatry and child psychiatry at Creighton University. Dr. Bhatia is board-certified in psychiatry, child and adolescent psychiatry, addiction psychiatry and forensic psychiatry.

REFERENCES

Weissman MM, Olfson M. Depression in women: implications for health care research. Science 1995;269:799-801.
Kornstein SG. Gender differences in depression: implications for treatment. J Clin Psychiatry 1997; 58(suppl 15):12-8.
Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998;338:209-16.
Seeman MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997;154:1641-7.
American College of Obstetrics and Gynecology. Depression in women: ACOG technical bulletin number 182--July 1993. Int J Gynecol Obstet 1993; 43:203-11.
Slap GB. Oral contraceptives and depression: impact, prevalence, and course. J Adolesc Health 1981;2:53-64.
Pajer K. New strategies in the treatment of depression in women. J Clin Psychiatry 1995;56(suppl 2):30-7.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, D.C.: American Psychiatric Association, 1994.
Leibenluft E, Hardin TA, Rosenthal NE. Gender differences in seasonal affective disorder. Depression 1995;3:13-9.
Hirschfeld RM, Russell JM. Assessment and treatment of suicidal patients. N Engl J Med 1997;337: 910-5.
Depression in primary care: detection, diagnosis, and treatment. Rockville, Md.: U.S. Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, 1993; AHCPR publication no. 93-0552.
Moscicki EK. Gender differences in completed and attempted suicides. Ann Epidemiol 1994;4:152-8.
McGrath E, ed. Women and depression: risk factors and treatment issues. Washington, D.C: American Psychological Association, 1990.
Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-95.
Rubinow DR. The premenstrual syndrome. New views. JAMA 1992;268:1908-12.
Pearlstein TB, Frank E, Rivera-Tovar A, Thoft JS, Jacobs E, Mieczkowski T. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 1990;20:129-34.
Pearlstein T. Nonpharmacologic treatment of premenstrual syndrome. Psychiatr Ann 1996;26:590-4.
Gelenberg AJ. Treating PMS. Biol Ther Psychiatry 1997;20:1.
Yonkers KA, Brown WA. Pharmacologic treatments for premenstrual dysphoric disorder. Psychiatr Ann 1996;26:586-9.
Schmidt PJ, Grover GN, Rubinow DR. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 1993;50:467-73.
Freeman E, Rickels K, Sondheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 1990;264: 349-53.
Gelenberg AJ. SSRIs for PMDD. Biol Ther Psychiatry 1998;21:13-4.
Mortola JF, Girton L, Fisher U. Successful treatment for severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol 1991;72:252A-F.
Harrison WM, Endicott J, Nee J. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry 1990;47:270-5.
Poffenbarger RS Jr. Epidemiological aspects of mental illness associated with childbearing. In: Brockington IF, Kunear R, eds. Motherhood and mental illness. New York: Grune & Stratton, 1982: 19-36
Altshuler LL, Hendrick V, Cohen LS. Course of mood and anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry 1998;59(suppl 2):29-33.
McElhatton PR, Garbis HM, Elefant E, Vial T, Bellemin B, Mastroiacovo P, et al. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Service (ENTIS). Reprod Toxicol 1996;10:285-94.
Cohen LS, Rosenbaum JF. Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry 1998;59(suppl 2):18-28.
Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.
Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, et al. Pregnancy outcome following maternal use of new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998;279:609-10.
Physician's desk reference. 52nd ed. Montvale, N.J.: Medical Economics, 1998.
Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998;338:1128-37.
Nonacs R, Cohen LS. Postpartum mood disorders: diagnosis and treatment guidelines. J Clin Psychiatry 1998;59(suppl 2):34-40.
American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137-50.
Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994;45: 444-50.
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-6.
Gregoire AJ, Kumar B, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996;347:930-3.

Copyright © 1999 by the American Academy of Family Physicians.

References for article

top ~ depression homepage

HealthyPlace.com Depression Center Links
home ~ site map ~ causes ~ types ~ people ~ living with
treatments ~ self-help ~ support ~ suicide ~ related issues

HealthyPlace.com Homepage
Chat ~ Forums ~ Communities
HealthyPlace.com Films ~ HealthyPlace.com Radio ~ News
Site Map ~ Web Tour ~ Advertise ~ Email Us
send this page to a friend

We subscribe to the HONcode principles of the Health On the Net Foundation.